(
189
Results
)
Filter
Only match titles
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Exploring the AXIS communications in allergy and chronic diseases
-
Flash Talks on rhinosinusitis and nasal polyps
-
Ligelizumab in adolescent patients with chronic spontaneous urticaria: results from a dedicated phase 2b study
-
Management of Chronic Urticaria and involving the patient
-
New mechanisms for chronic diseases
-
Trichinella spiralis infection associated with chronic spontaneous urticaria – case series
-
When hives are not chronic urticaria
-
Assessing Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) severity by JESREC algorithm
-
Chronic rhinosinusitis with nasal polyps
-
Endotype-driven treatment in chronic rhinosinusitis
-
Endotyping chronic rhinosinusitis for a better treatment approach
-
Novel insights into chronic rhinosinusitis with nasal polyps
-
Real-life evidence of the burden of chronic rhinosinusitis (CRS)
-
The clinical case of the great dupilumab efficacy in the treatment of the severe asthma comorbid with chronic rhinosinusitis with nasal polyps
Show more Event Resources (12)Show Less-
-
Asking the right questions: From precision medicine to personalized health care in patients with refractory or unexplained chronic cough
-
Chronic spontaneous urticaria: defining the pathway to successful management
-
Complete control of chronic spontaneous urticaria – mission (im)possible?
-
Exploring the Complexity of Chronic Spontaneous Urticaria
-
How can we improve the approach to treating chronic urticaria in children?
-
Mind the PAF: a new route to managing chronic urticaria and allergic diseases?
-
Refractory Chronic Cough: A Symptom or a Disease?
Show more Sponsored Symposia (5)Show Less-
-
Distinct expression of SARS- CoV-2 receptor ACE2 correlates with endotypes of rhinosinusitis with nasal polyps
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticaria
-
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic – An EAACI Position Paper
-
Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitis
Show more Covid-19 (2)Show Less-
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria Taskforce
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paper
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)
-
Metabolic pathways in immune senescence and inflammaging: Novel therapeutic strategy for chronic inflammatory lung diseases. An EAACI position paper from the Task Force for Immunopharmacology
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paper
Show more Position Papers (3)Show Less-
Website
Collapse
-
A case of chronic cough induced by esophageal hypersensitivity
-
A critical analysis of Chat-GPT’s replies to inquiries about chronic urticaria, focusing on the information’s reliability, accuracy, content, and readability
-
A novel approach of pooling donors for basophil testing to diagnose type 2 autoimmune chronic spontaneous urticaria
-
A randomized, double-blind, phase 2a study of covalent Bruton’s tyrosine kinase inhibitor TAS5315 in patients with chronic spontaneous urticaria with an inadequate response to H1-antihistamines
-
A rare case of chronic non-bacterial osteomyelitis/chronic recurrent multifocal osteomyelitis (CNO/CRMO) complicated by a Diffuse Large B-Cell Lymphoma (DLBCL)
-
Advances in Chronic Urticaria treatment
-
Alteration of the Airway Microbiota is Associated with the Progression of Post-COVID-19 Chronic Cough in Adults
-
Anti IgE for the treatment of chronic urticarial
-
Association between Acinetobacter baumannii-derived extracellular vesicles and chronic urticaria
-
Autoimune Chronic Urticaria Preceeding Sisitemic Lupus Erythematous
-
Barzolvolimab Significantly Improves Angioedema in Patients with Chronic Spontaneous Urticaria (CSU): Results from a Phase 2 Trial
-
Beneficial role of Psychotherapeutic Interventions in Managing Chronic Spontaneous Urticaria Refractory to Omalizumab – A Case Study
-
Chronic Spontaneous Urticaria Patients in Latvia: Epidemiological and Clinical Characteristics
-
Chronic Urticaria in Adolescence – An unusual association
-
Chronic Urticaria in Childhood: time for a review
-
Chronic Urticaria: challenges in childhood
-
Chronic hand eczema – updated guidelines
-
Chronic inducible urticaria: classification and prominent features of physical and non-physical types
-
Chronic nasal obstruction
-
Chronic spontaneous urticaria in Japan: real-world prevalence, treatments and healthcare resource utilisation based on a health insurance database
-
Chronic spontaneous urticaria in children: Series of 10 cases
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Chronic urticaria across the ages: clinical features, comorbidities, and treatment response
-
Clinical Characteristics and Natural Course of Chronic Inducible Urticaria in a Pediatric Cohort
-
Clinical perspectives in chronic urticaria: from etiology to severity and prognosis
-
Comparable Efficacy and Pharmacodynamic Results of CT-P39 to Reference Omalizumab in Patients with Chronic Spontaneous Urticaria
-
Comparison of Component Resolved Diagnosis (CRD) with skin prick test in respiratory allergy [36 cases] and Significance of CRD in Anaphylaxis [8 cases] & Chronic Urticaria with/ without Angioedema [16 cases]
-
Cost Of Illness Analysis of Chronic Urticaria in 5 Latin American Countries: Diagnostic and Therapeutic Expenses
-
Diet modification recommendation for Chronic Spontaneous Urticaria patients -Albanian Allergists approach
-
Do air pollution and weather affect chronic urticaria attack frequency?
-
Dupilumab as effective treatment for chronic pruritus: a case report
-
EAACI & WAO Joint Symposium : World Allergy Forum – Is the Burden of Chronic Cough Underappreciated in Allergy Practice?
-
Effect of Remibrutinib on Disease Activity in Patients with Chronic Spontaneous Urticaria: Post Hoc Analysis of Phase 3 REMIX-1 and REMIX-2 studies
-
Effect of Remibrutinib on Sleep and Daily Activities in Patients With Chronic Spontaneous Urticaria: Results From the Phase 3 Studies
-
Efficacy and injection schedule adjustment of Dupilumab in patients with chronic rhinosinusitis: Recent experiences in SNUH
-
Efficacy and safety of switching to bilastine, a histamine H1 receptor antagonist, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a phase IV, multicenter, open-label, randomized, parallel-group comparative controlled trial
-
Efficacy and safety of therapy with omalizumab in children with chronic spontaneous urticaria
-
Efficacy of Omalizumab in Food Allergy Management in a Patient with Chronic Spontaneous Urticaria
-
Exploring Drug Hypersensitivity in Pediatric Patients with Chronic Spontaneous Urticaria: ‘’A Comprehensive Analysis Using Diagnostic Tests”
-
Exploring a beta-lactoglobulin-based food for specific medical purposes (FSMP) for dietary management of chronic inflammation in atopic dermatitis: insights from mouse studies
-
GSK – Refractory Chronic Cough: A Symptom or a Disease?
-
Gain-of-function mutations of human MRGPRX2 in the Chronic spontaneous urticaria
-
Hereditary angioedema and severe chronic urticaria, what the odds?
-
How can we improve the approach to treating chronic urticaria in children?
-
Hypoallergenic and anti-remodeling effect of a hybrid protein in a murine model of chronic asthma induced by Dermatophagoides pteronyssinus
-
IgE and Eosinophils levels may predict Successful Omalizumab withdrawal in chronic spontaneous urticaria
-
Impact of asthma as a chronic disease on the quality of life of the patient and his family
-
Incidence of allergic rhinitis in different age group rhinosinusitis
-
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
-
Infection History and Risk of Chronic Inflammatory Airway Diseases; A Real-World Hospital Cohort Study
-
Is it possible to use the platelet and neutrophil lymphocyte ratios and systemic immune inflammation index as potential biomarkers for chronic urticaria?
-
Knowledge and satisfaction about the use of Patient Reported Outcomes Measures (PROMs) by patients with chronic urticaria
-
LAD2 Mast Cell Activation Test in Chronic Spontaneous Urticaria
-
Linguistic Adaptation of Urticaria Activity Score Over 7 Days (UAS7) to Latvian: Evaluating Disease Activity in Adult Patients with Chronic Spontaneous Urticaria in Latvia
-
Long-Term Efficacy and Safety of Remibrutinib in Patients with Chronic Spontaneous Urticaria in the Phase 3 REMIX-1 and REMIX-2 Studies
-
Minimal persistent inflammation in chronic spontaneous urticaria patients with clinical remission
-
Next generation sequencing analysis in H1-antihistamine-refractory chronic spontaneous urticaria
-
Omalizumab and chronic spontaneous urticaria: ‘one dose does not fit all’
-
Optimizing Omalizumab Therapy in Chronic Urticaria: Tailored Approaches for Weaning and Sustained Remission
-
Physicians’ prescribing patterns and perceptions of treatments for chronic spontaneous urticaria: Real world data from Urticaria Voices
-
Practical applications of ‘omics’ in chronic airway disease
-
Predicting Responses to Omalizumab in Antihistamine-Refractory Chronic Urticaria
-
Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients
-
Predictive role of peripheral blood Plasma MRGPRX2 expression to the response of anti-histamine treatment in the Chronic spontaneous urticaria patients
-
Prevalence of Severe Atopic Dermatitis and Comorbid Chronic Systemic Diseases is Increasing in Korean Children and Adolescents
-
Real world long-term data effectiveness of rupatadine in chronic urticaria: retrospective, monocentric, observational study
-
Reduction in Weekly Urticaria Activity Score (UAS7) With Rilzabrutinib in Patients With Chronic Spontaneous Urticaria: 12-Week Results From the RILECSU Phase 2 Dose-Ranging Study
-
Refractory Chronic Cough: A Symptom or a Disease?
-
Rhinosinusitis
-
Rilzabrutinib Reduces IgG Anti-Thyroid Peroxidase (anti-TPO), Soluble Mas-Related G Protein-Coupled Receptor X2 (sMRGPRX2) and Eosinophils at 12 Weeks in Patients With Chronic Spontaneous Urticaria
-
Rilzabrutinib Results in Rapid Improvement of Symptoms in Patients With Chronic Spontaneous Urticaria: Results From the RILECSU Phase 2 Dose-Ranging Study
-
SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis
-
Safety of Remibrutinib in Patients With Chronic Spontaneous Urticaria: Results From the Phase 3 REMIX-1 and REMIX-2 Studies
-
Sensitization to three species of mites in patients with chronic rhinitis in a tropical region of Latin America
-
Successful administration of omalizumab following anaphylaxis in a patient with chronic idiophatic urticaria
-
The BEACON Study: A Phase 1b/2a, Dose Escalation Study of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of the c-Kit Mab Briquilimab in Adults with symptomatic Chronic Spontaneous Urticaria (CSU)
-
The UCARE Study on the Prevalence of Sleep Disorders and Nighttime Bruxism in People with Chronic Urticaria
-
The association between baseline IgE levels and response to standard-dose omalizumab in uncontrolled chronic urticaria patients
-
The association between baseline IgE levels and response to standard-dose omalizumab in uncontrolled chronic urticaria patients
-
The autologous serum skin test (ASST) predicts the response to anti-IgE treatment in Chronic Spontaneous Urticaria patients: a prospective study
-
The challenge of chronic urticaria management
-
Topical steroids in infants and childen with chronic eczema.
-
Treatment of Chronic Spontaneous Urticaria with Omalizumab Complicated by Onychodystrophy?
-
Treatment of Chronic Spontaneous Urticaria with Omalizumab during Pregnancy- Experience in a Portuguese Ucare
-
Use of nasal irrigation as add on therapy to non responders to pharmacotherapy in chronic adenoiditis
-
What can we now do for chronic cough?
-
What to examine when you consider chronic urticaria
-
World Allergy Forum – Is the Burden of Chronic Cough Underappreciated in Allergy Practice?
-
Worldwide experiences and unmet needs of patients with chronic spontaneous urticaria and treating physicians: The Urticaria Voices study
-
Аnti-inflammatory effect of extracorporeal shock wave therapy as treatment for chronic calculous prostatitis
-
A predictive model to differenciate chronic histaminergic angiodema and chronic spontaneous urticaria with angioedema
-
A predictive model to differenciate chronic histaminergic angiodema and chronic spontaneous urticaria with angioedema
-
ANCHOR-1 and 2 Study Design: Replicate Phase 3 Randomised, Double-Blind, Placebo-Controlled Studies of the Efficacy and Safety of Depemokimab in Patients with Chronic Rhinosinusitis with Nasal Polyps
-
Advancements and Key Insights in Chronic Rhinosinusitis (CRS) Management
-
Allergen Immunotherapy decreases biologicals use in allergic rhinitis with chronic rhinosinusitis with nasal polyps (CRSwNP)
-
Artificial intelligence-assisted prediction of olfactory disorders in patients with chronic rhinosinusitis
-
Baseline Disease Characteristics Among Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma in the Global AROMA Registry
-
Challenges in Biologics for Chronic Rhinosinusitis with Nasal Polyps
-
Changes in pathological characteristics and influence factors of chronic rhinosinusitis in the Greater Bay Area of China: A retrospective study on whole slide image-based of artificial intelligence
-
Characteristics of patients with chronic rhinosinusitis with nasal polyps and allergic rhinitis enrolled in the global AROMA registry
-
Chronic rhinosinusitis among young adults is strongly associated with atopy and signs of type-1 inflammation
-
Chronic rhinosinusitis with nasal polyposis: an old problem with a new solution
-
CosMx™ single cell spatial imaging identifies changes in spatial cell communication in chronic rhinosinusitis with nasal polyps following anti – IL-5 treatment
-
Deep immune profiling of chronic rhinosinusitis in allergic and non-allergic cohorts using mass cytometry
-
Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of tezepelumab in adult patients with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT)
-
Determinants of Adherence of Biologic Therapies in Chronic Rhinosinusitis
-
Doxycycline therapy reduced local nasal inflammation and promoted wound healing after FESS in Chronic Rhinosinusitis patients
-
Dual monoclonal antibody therapy in a patient with chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma: a case report and proteome analysis
-
Dupilumab Restores Barrier Function of Nasal Epithelial Cells and Decreases Type-2 Inflammatory Markers in Chronic Rhinosinusitis with Nasal Polyps
-
Dupilumab-induced eosinophilia in patients with diffuse type 2 chronic rhinosinusitis
-
Dupilumab-induced skin reaction in a patient with severe asthma and chronic rhinosinusitis with nasal polyposis and without prior skin conditions
-
Early Responders within One Month of Dupilumab Treatment for Chronic Rhinosinusitis with Nasal Polyps
-
Effect of Dupilumab on Radiological Remission in Patients with Chronic Rhinosinusitis with Nasal Polyp: A step Toward Clinical Remission
-
Effect of anti IL-5/IL-5Rα biological treatment on tissue eosinophil subpopulations in patients affected by Chronic Rhinosinusitis with Nasal Polyp
-
Effectiveness and Safety of Dupilumab in patients with chronic rhinosinusitis with nasal polyps After One Year of Therapy: Results from a real-world non-interventional study in Germany (ProGNOSE)
-
Effects of Dupilumab on Eosinophil Subpopulations and Inflammation in Chronic Rhinosinusitis with Nasal Polyps
-
Efficacy of Dupliuzumab in the treatment of atopic dermatitis complicated by chronic rhinosinusitis with nasal polyps
-
Endotyping chronic rhinosinusitis for a better treatment approach
-
Eosinophilic Chronic Rhinosinusitis with Nasal Polyps : Current Perspective
-
Evaluation of Early Real-World Efficacy and Safety of Mepolizumab in Chronic Rhinosinusitis with Nasal Polyposis Through a Multidisciplinary Approach
-
Features of chronic spontaneous urticaria in patients with atopic comorbidities: Results from CURE, the chronic urticaria registry
-
Improvement in Olfactory Training for Postoperative Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps
-
Initiation of dupilumab led to reduced use of corticosteroids and antibiotics over 12 months in patients with chronic rhinosinusitis with nasal polyps treated in US real world practice
-
Inotodiol attenuates mucosal inflammation in a mouse model of eosinophilic chronic rhinosinusitis
-
Local nasal inflammation and postoperative wound healing is improved by postoperative doxycycline therapy after FESS in Chronic Rhinosinusitis patients
-
Longitudinal Assessment of Dupilumab’s Therapeutic Effects in Chronic Rhinosinusitis with Nasal Polyps
-
Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology
-
Modulation of eosinophilic and neutrophilic inflammation in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab, assessed by nasal cytology and biopsy histology
-
Nasal microbiome in chronic rhinosinusitis
-
Performance of 5 item and 22 item sino-nasal outcome tests in response to dupilumab in chronic rhinosinusitis with nasal polyps
-
Platycodon D protects human nasal epithelial cells from pyroptosis through the Nrf2/HO-1/ROS signaling cascade in chronic rhinosinusitis
-
Predictive model for postoperative unrecovered olfactory function in chronic rhinosinusitis patients with olfactory disorder
-
Proteomic analysis identifies patients with chronic rhinosinusitis with nasal polyps who are responders and non-responders to benralizumab (NAPPREB study)
-
Real-Life Effectiveness of Mepolizumab and Omalizumab in Sever Uncontrolled Chronic Rhinosinusitis with Nasal Polyps: A Prospective Study
-
Real-Life effectiveness of a Cohort of Patients with Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP) and Concomitant Moderate Persistent Asthma Treated with Dupilumab
-
Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
-
Real-world data show sustained therapeutic effects of dupilumab in chronic rhinosinusitis with nasal polyps (CRSwNP) over 3 years
-
Real-world effectiveness of dupilumab in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) is independent of comorbidities, sinus surgery history and level of type 2 inflammation: Findings from CHRINOSOR
-
Regulatory T cells act as the guardians of mucosal immune homeostasis in chronic rhinosinusitis
-
SNOT-22 and olfactory perception in Chronic Rhinosinusitis with Nasal Polyps: A Retrospective Observational Study
-
Sequence of improvements in objective and patient-reported outcomes with dupilumab treatment in patients with chronic rhinosinusitis with nasal polyps: Analysis of the SINUS-52 study
-
The Influence of Dupilumab on the Nasal and Gastrointestinal Microbiome in Diffuse Type 2 Chronic Rhinosinusitis
-
The Relationship Between Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) and Serum Mas-Related G-Protein Coupled Receptor-X2 (MRGPRX2) Level
-
The Role of Rho GTPase Signaling on Epithelial-Mesenchymal Transition and Inflammation of Chronic Rhinosinusitis with Nasal Polyp
-
The impact of intranasal corticosteroids on exhaled nitric oxide in chronic eosinophilic rhinosinusitis with nasal polyposis after surgery
-
The impact of secretory IgA on nasal microbiome control and its link to the development of chronic rhinosinusitis
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
The multi-omics single-cell landscape of sinus mucosa in uncontrolled severe chronic rhinosinusitis with nasal polyps
-
The upper airway microbiome – potential target in chronic rhinosinusitis
-
Understanding and managing Chronic Rhinosinusitis with Nasal Polyps
-
The correlation between chronic rhinosinusitis with/without nasal polyp and chronic kidney disease: a longitudinal follow-up study
Show more Sessions (149)Show Less-